Merck Covered Calls in $6.6B ETF Push Yield Above 6%, Cap Upside
Merck is a top holding in the $6.6 billion Amplify Enhanced Dividend Income ETF, which writes covered calls on Merck options with February and March expirations to boost its yield above 6%. This strategy supported DIVO’s 73% five-year return but caps Merck’s upside potential for ETF investors.
1. DIVO's Merck Exposure and Covered Call Strategy
The $6.6 billion Amplify Enhanced Dividend Income ETF holds Merck shares alongside other blue-chip names and writes covered calls on select positions, including options with February and March 2026 expirations. The premium from these short calls elevates the fund’s yield above 6%, contributing to its strong income profile without sacrificing capital growth entirely.
2. Implications for Merck Share Dynamics
By capping upside on Merck stock through covered calls, the ETF limits potential share price gains for its investors when Merck rallies. This structure may influence demand and trading patterns for Merck shares within the ETF, potentially muting volatility and affecting overall liquidity dynamics.